C. Marguerie, C. Bunn, H. Beynon, R. Bernstein, J. Hughes et al., Polymyositis, Pulmonary Fibrosis and Autoantibodies to Aminoacyl-tRNA Synthetase Enzymes, QJM, vol.77, issue.1, pp.1019-1038, 1990.
DOI : 10.1093/qjmed/77.1.1019

I. Marie, S. Dominique, A. Janvresse, H. Levesque, and J. Menard, Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome, Respiratory Medicine, vol.106, issue.4, pp.581-587, 2012.
DOI : 10.1016/j.rmed.2012.01.001

I. Marie, S. Josse, P. Hatron, S. Dominique, E. Hachulla et al., Interstitial Lung Disease in Anti-Jo-1 Patients With Antisynthetase Syndrome, Arthritis Care & Research, vol.37, issue.Suppl, pp.800-808
DOI : 10.1002/acr.21895

E. Katzap, M. Barilla-labarca, and G. Marder, Antisynthetase Syndrome, Current Rheumatology Reports, vol.65, issue.7, pp.175-181, 2011.
DOI : 10.1007/s11926-011-0176-8

L. Love, R. Leff, D. Fraser, I. Targoff, M. Dalakas et al., A New Approach to the Classification of Idiopathic Inflammatory Myopathy, Medicine, vol.70, issue.6, pp.360-374, 1991.
DOI : 10.1097/00005792-199111000-00002

M. Späth, M. Schröder, B. Schlotter-weigel, M. Walter, H. Hautmann et al., The long-term outcome of anti-Jo-1-positive inflammatory myopathies, J Neurol, vol.251, pp.859-864, 2004.

A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-347, 1975.
DOI : 10.1056/NEJM197502132920706

A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.8, pp.403-407, 1975.
DOI : 10.1056/NEJM197502202920807

I. Marie, E. Hachulla, P. Hatron, M. Hellot, H. Levesque et al., O97 Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis, European Journal of Internal Medicine, vol.14, pp.2230-2237, 2001.
DOI : 10.1016/S0953-6205(03)91246-5

P. Quanjer, Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests, Bull Eur Physiopathol Respir, vol.19, pp.1-95, 1983.

I. Marie, P. Hatron, S. Dominique, C. P. Mouthon, L. Menard et al., Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients, Arthritis & Rheumatism, vol.41, issue.Suppl 5, pp.3439-3447, 2011.
DOI : 10.1002/art.30513

A. Clarke, D. Bloch, T. Medsger, . Jr, and C. Oddis, A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis, Arthritis & Rheumatism, vol.4, issue.9, pp.1218-1224, 1995.
DOI : 10.1002/art.1780380907

K. Dankó, A. Ponyi, T. Constantin, G. Borgulya, and G. Szegedi, Long-Term Survival of Patients With Idiopathic Inflammatory Myopathies According to Clinical Features, Medicine, vol.83, issue.1, pp.35-42, 2004.
DOI : 10.1097/01.md.0000109755.65914.5e

K. Henriksson and P. Sandstedt, Polymyositis - treatment and prognosis, Acta Neurologica Scandinavica, vol.263, issue.4, pp.280-300, 1982.
DOI : 10.1111/j.1600-0404.1982.tb03087.x

M. Hochberg, D. Lopez-acuna, and A. Gittelsohn, Mortality from polymyositis and dermatomyositis in the united states, 1968???1978, Arthritis & Rheumatism, vol.14, issue.12, pp.1465-1471, 1968.
DOI : 10.1002/art.1780261208

E. Koh, A. Seow, B. Ong, P. Ratnagopal, H. Tjia et al., Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients., Annals of the Rheumatic Diseases, vol.52, issue.12, pp.857-861, 1993.
DOI : 10.1136/ard.52.12.857

S. Sultan, Y. Ioannou, K. Moss, and D. Isenberg, Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality, Rheumatology, vol.41, issue.1, pp.22-26, 2002.
DOI : 10.1093/rheumatology/41.1.22

I. Uthman, D. Vázquez-abad, and J. Senécal, Distinctive features of idiopathic inflammatory myopathies inFrench Canadians, Seminars in Arthritis and Rheumatism, vol.26, issue.1, pp.447-458, 1996.
DOI : 10.1016/S0049-0172(96)80025-4

Y. Yamasaki, H. Yamada, M. Ohkubo, M. Yamasaki, K. Azuma et al., Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan, The Journal of Rheumatology, vol.38, issue.8, pp.1636-1643, 2011.
DOI : 10.3899/jrheum.101002

M. Joffe, L. Love, R. Leff, D. Fraser, I. Targoff et al., Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy, The American Journal of Medicine, vol.94, issue.4, pp.379-387, 1993.
DOI : 10.1016/0002-9343(93)90148-I

I. Marie and L. Mouthon, Therapy of polymyositis and dermatomyositis, Autoimmunity Reviews, vol.11, issue.1, pp.6-13, 2011.
DOI : 10.1016/j.autrev.2011.06.007

A. Ponyi, G. Borgulya, T. Constantin, A. Váncsa, L. Gergely et al., Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis, Rheumatology, vol.44, issue.1, pp.83-88, 2005.
DOI : 10.1093/rheumatology/keh404

R. Aggarwal, E. Cassidy, N. Fertig, D. Koontz, M. Lucas et al., Oddis CV: Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients, Ann Rheum Dis. in press, pp.10-1136

E. Schiopu, K. Phillips, P. Macdonald, L. Crofford, and E. Somers, Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine, Arthritis Research & Therapy, vol.14, issue.1, p.22, 2012.
DOI : 10.1002/art.24904

I. Marie, J. Menard, P. Hatron, E. Hachulla, L. Mouthon et al., Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients, Arthritis Care & Research, vol.10, issue.12, pp.1748-1755, 2010.
DOI : 10.1002/acr.20325

R. Oddiscv, . Aggarwalr, . Riderlg, . Aschermandp, . Levesquemc et al., Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial, Arthritis & Rheumatism, vol.59, issue.2, pp.314-324, 2013.
DOI : 10.1002/art.37754

I. Marie, P. Hatron, H. Levesque, E. Hachulla, M. Hellot et al., Influence of Age on Characteristics of Polymyositis and Dermatomyositis in Adults, Medicine, vol.78, issue.3, pp.139-147, 1999.
DOI : 10.1097/00005792-199905000-00001

R. Buchbinder, A. Forbes, S. Hall, X. Dennett, and G. Giles, Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study, Annals of Internal Medicine, vol.134, issue.12, pp.1087-1095, 2001.
DOI : 10.7326/0003-4819-134-12-200106190-00008

D. Legault, J. Mcdermott, A. Crous-tsanaclis, and G. Boire, Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome, J Rheumatol, vol.35, pp.169-171, 2008.

A. Rozelle, S. Trieu, and L. Chung, Malignancy in the Setting of the Anti-Synthetase Syndrome, JCR: Journal of Clinical Rheumatology, vol.14, issue.5, pp.285-288, 2008.
DOI : 10.1097/RHU.0b013e31817d116f

K. Yu, Y. Wu, C. Kuo, L. See, Y. Shen et al., Survival analysis of patients with dermatomyositis and polymyositis, Clinical Rheumatology, vol.12, issue.12, pp.1595-1601, 2011.
DOI : 10.1007/s10067-011-1840-0

C. Torres, R. Belmonte, L. Carmona, F. Gómez-reino, M. Galindo et al., Survival, mortality and causes of death in inflammatory myopathies, Autoimmunity, vol.125, issue.3, pp.205-215, 2006.
DOI : 10.1016/0049-0172(86)90014-4

I. Marie, L. Lahaxe, O. Benveniste, K. Delavigne, D. Adoue et al., Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody, British Journal of Dermatology, vol.141, issue.2, pp.337-344, 2010.
DOI : 10.1111/j.1365-2133.2009.09484.x